← Evidence map

ReviewCurrent pharmaceutical design2013

Targeting the ubiquitin-mediated proteasome degradation of p53 for cancer therapy.

Tiffany Devine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23151129